View in EDS

Interleukin-18 armours antitumour immune effectors.

Saved in:

Bibliographic Details
Title:	Interleukin-18 armours antitumour immune effectors.
Authors:	Sharma A; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Bishara GG; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Olejniczak SH; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ohm JE; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Brentjens RJ; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. renier.brentjens@roswellpark.org.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. renier.brentjens@roswellpark.org., Gupta A; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. ajay.gupta@roswellpark.org.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. ajay.gupta@roswellpark.org.; Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. ajay.gupta@roswellpark.org.
Source:	Nature reviews. Immunology [Nat Rev Immunol] 2026 Jul 16. Date of Electronic Publication: 2026 Jul 16.
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1741 (Electronic) Linking ISSN: 14741733 NLM ISO Abbreviation: Nat Rev Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1474-1741
DOI:	10.1038/s41577-026-01330-1